SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-013494
Filing Date
2023-08-07
Accepted
2023-08-07 08:11:48
Documents
66
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q sgtx-20230630x10q.htm   iXBRL 10-Q 1865939
2 EX-10.1 sgtx-20230630xex10d1.htm EX-10.1 107868
3 EX-10.2 sgtx-20230630xex10d2.htm EX-10.2 104516
4 EX-10.3 sgtx-20230630xex10d3.htm EX-10.3 85232
5 EX-10.4 sgtx-20230630xex10d4.htm EX-10.4 20034
6 EX-31.1 sgtx-20230630xex31d1.htm EX-31.1 36594
7 EX-31.2 sgtx-20230630xex31d2.htm EX-31.2 36597
8 EX-32.1 sgtx-20230630xex32d1.htm EX-32.1 15201
  Complete submission text file 0001558370-23-013494.txt   7186908

Data Files

Seq Description Document Type Size
9 EX-101.SCH sgtx-20230630.xsd EX-101.SCH 41869
10 EX-101.CAL sgtx-20230630_cal.xml EX-101.CAL 51902
11 EX-101.DEF sgtx-20230630_def.xml EX-101.DEF 138554
12 EX-101.LAB sgtx-20230630_lab.xml EX-101.LAB 402861
13 EX-101.PRE sgtx-20230630_pre.xml EX-101.PRE 280130
60 EXTRACTED XBRL INSTANCE DOCUMENT sgtx-20230630x10q_htm.xml XML 1138440
Mailing Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142 617-336-7540
Sigilon Therapeutics, Inc. (Filer) CIK: 0001821323 (see all company filings)

IRS No.: 474005543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39746 | Film No.: 231145727
SIC: 2834 Pharmaceutical Preparations